The mutant KRAS gene is involved in the NSCLC-generated EVs-mediated transition of naive CD4+ T cells towards a FoxP3+ T-reg phenotype in a cytokine-independent manner in an NSCLC xenograft mouse model [189]. Here, KRAS is linked to non-small cell lung carcinoma.